Medtronic's Abre Venous Self-Expanding Stent System Shows Sustained Effectiveness at 36 Months
October 14, 2022—Medtronic announced that the 36-month, final results from the ABRE clinical study were presented by Professor Stephen Black, MD
Source: evtoday.com